Free Trial

Hemispherx BioPharma (HEB) SEC Filings & 10K Form

Hemispherx BioPharma logo
$0.21 0.00 (0.00%)
(As of 11/22/2024 ET)

Recent Hemispherx BioPharma SEC Filings

DateFilerForm TypeView
11/21/2024
11:02 AM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
11:04 AM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
11:46 AM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:59 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form DEFA14A
11/14/2024
3:25 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
Form DFAN14A
11/14/2024
2:21 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
11/06/2024
8:02 AM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
Form DEFC14A
11/04/2024
3:59 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form DEFA14A
11/04/2024
6:00 AM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Form DEFC14A
10/30/2024
3:50 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form PRER14A
10/30/2024
11:53 AM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
Form PRRN14A
10/18/2024
3:34 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
Form PREC14A
10/15/2024
3:33 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Form PREC14A
10/01/2024
2:55 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
12:12 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 424B5
09/30/2024
7:22 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 424B5
09/17/2024
11:05 AM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
2:45 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:15 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:45 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
4:40 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
Form SC 13D/A
09/03/2024
8:43 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
Form SC 13D/A
08/14/2024
6:37 AM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
Form SC 13D/A
08/12/2024
8:39 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:41 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
5:05 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:14 AM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
Form SC 13D/A
07/25/2024
11:15 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form EFFECT
07/25/2024
4:00 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 424B5
07/15/2024
4:00 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
4:19 PM
Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
Form SC 13D/A
07/11/2024
4:16 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/03/2024
9:15 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
9:05 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 424B5
05/31/2024
7:14 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 424B5
05/07/2024
7:30 AM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:30 AM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
11:16 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form EFFECT
05/01/2024
3:35 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 424B5
03/29/2024
8:18 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
12:52 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
03/27/2024
12:54 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
12:30 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
2:01 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
2:01 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
2:01 PM
Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:37 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form D/A
02/09/2024
2:47 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
12:42 PM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
7:45 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
7:15 AM
Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:HEB) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners